Skip to main content

Table 1 Summary of patients’ clinicopathological characteristics

From: Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study

Variables

Sub variables

Total

D1

D2/D3

D4

Number of patients

 

532 (100%)

263 (49.4%)

223 (41.9%)

46 (8.6%)

Gender

Male

335 (63.0%)

162 (61.6%)

141 (63.2%)

32 (69.6%)

Female

197 (37.0%)

101 (38.4%)

82 (36.8%)

14 (30.4%)

Age, years

<65

141 (29.1%)

77 (29.3%)

45 (20.2%)

19 (41.3%)

≥65

391 (70.9%)

186 (70.7%)

178 (79.8%)

27 (58.7%)

Race

Asian

523 (96.4%)

257 (97.7%)

220 (98.7%)

46 (100%)

Others

9 (3.6%)

6 (2.3%)

3 (1.3%)

0 (0.0%)

Histology grade

W/M**

407 (76.5%)

198 (75.3%)

172 (77.1%)

37 (80.4%)

Poorly

125 (23.5%)

65 (24.7%)

51 (22.9%)

9 (19.6%)

Tumor size

<5 cm

397 (75.4%)

195 (69.5%)

169 (75.8%)

33 (71.7%)

≥5 cm

135 (24.6%)

68 (30.5%)

54 (24.2%)

13 (28.3%)

Tumor stage

T1/T2

393 (73.9%)

190 (72.2%)

166 (74.4%)

37 (80.4%)

T3/T4

139 (26.1%)

73 (27.8%)

57 (25.6%)

9 (19.6%)

Manual grade

low

282 (69.2%)

181 (68.8%)

156 (70.0%)

31 (67.4%)

high

164 (30.8%)

82 (31.2%)

67 (30.0%)

15 (32.6%)

Location

Right

278 (52.3%)

134 (50.9%)

117 (52.5%)

27 (58.7%)

Left

254 (47.7%)

129 (49.1%)

106 (47.5%)

19 (41.3%)

MSI status

MSS/MSS-L

451 (84.8%)

219 (83.3%)

194 (87.0%)

38 (82.6%)

MSI-H

81 (15.2%)

44 (16.7%)

29 (13.0%)

8 (17.4%)

Perineural invasion

Yes

75 (14.1%)

36 (13.7%)

33 (14.8%)

6 (13.0%)

No

457 (85.9%)

227 (86.3%)

190 (85.2%)

40 (87.0%)

Vascular invasion

Yes

68 (12.8%)

33 (12.5%)

30 (13.5%)

5 (10.9%)

No

464 (87.2%)

230 (87.5%)

193 (86.5%)

41 (89.1%)

Recurrence

Yes

112 (21.1%)

58 (22.1%)

53 (23.8%)

6 (13.0%)

No

420 (78.9%)

205 (77.9%)

170 (76.2%)

40 (87.0%)

  1. W/M** well/moderately, MSI: MSI-L/H microsatellite instability—low/high, MSS microsatellite stable